Status: Recruiting
REMASTer: REcurrent Brain Metastases After SRS Trial
Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Participants needed: 261
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Monteris MedicalUpdated: Jun 18, 2026Locations: 9
Eligibility criteria
Patients with radiographically proven (by gadolinium-enhanced [Gd-] MRI) parench... [+14]
Patients with greater than 3 progressing lesions at time of enrollment. To class... [+11]